D-Glutamic acid

Pricing Availability   Qty
Cat.No. 0217 - D-Glutamic acid | C5H9NO4 | CAS No. 6893-26-1
Description: Endogenous, non-selective agonist. Less active enantiomer
Chemical Name: (R)-1-Aminopropane-1,3-dicarboxylic acid
Datasheet
Citations
Reviews
Literature (5)

Biological Activity

Excitatory amino acid acting at NMDA receptors; less active than the L-isomer.

L-isomer also available.

Technical Data

M. Wt 147.13
Formula C5H9NO4
Storage Store at RT
CAS Number 6893-26-1
PubChem ID 23327
InChI Key WHUUTDBJXJRKMK-GSVOUGTGSA-N
Smiles N[C@@]([H])([C@](O)=O)CCC(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data

Solubility Soluble to 100 mM in 1eq. NaOH

References

References are publications that support the biological activity of the product.

Olverman et al (1988) Structure/activity relations of N-MthD.-aspartate receptor ligands as studied by their inhibition of [3H]-D-2-amino-5-phosphonopentanoic acid binding in rat brain membranes. Neuroscience 26 17 PMID: 2901691

Watkins (1986) Twenty five years of excitatory amino acid research. Excitatory Amino Acids. Eds. Roberts et al. Macmil p1-39


If you know of a relevant reference for D-Glutamic acid, please let us know.

View Related Products by Product Action

View all Non-selective Ionotropic Glutamate Agonists

Keywords: D-Glutamic acid, D-Glutamic acid supplier, Endogenous, non-selective, agonists, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, Non-selective, mGlu, Amino, Acids, 0217, Tocris Bioscience

Citations for D-Glutamic acid

Citations are publications that use Tocris products.

Currently there are no citations for D-Glutamic acid. Do you know of a great paper that uses D-Glutamic acid from Tocris? Please let us know.

Reviews for D-Glutamic acid

There are currently no reviews for this product. Be the first to review D-Glutamic acid and earn rewards!

Have you used D-Glutamic acid?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Ion Channel

Ion Channel Product Listing

A collection of around 500 products for ion channel research, the listing includes research tools for the study of:

  • Ligand-gated ion channels
  • Voltage-gated ion channels
  • Other Ion Channels
Pain

Pain Research Product Guide

A collection of over 280 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Epilepsy

Epilepsy Poster

Epilepsy is a brain disease that affects 60 million people globally. More than 20 anti-seizure drugs are currently available, but these do not address the underlying causes of the condition. This poster summarizes current knowledge about the development of the condition and highlights some approaches that have disease-modifying effects in proof-of-concept studies.

Pain

Pain Poster

Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.

Parkinson's

Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.